A precision fermentation process by zuChem for producing high-purity, nature-identical mannitol, offering a sustainable, scalable alternative to traditional methods. Suitable for food and pharmaceutical applications, it enhances yield and reduces environmental impact.
zuChem has pioneered a precision fermentation process to produce nature-identical mannitol, a low-calorie sweetener widely used in food and pharmaceutical industries. This innovative method addresses the inefficiencies and environmental concerns of traditional chemical production, which relies on energy-intensive processes and toxic catalysts. By using renewable carbohydrate feedstocks, this solution promises scalable, consistent, and sustainable production of high-purity mannitol.
The technology currently stands at TRL 4, with successful bench and pilot-scale demonstrations. Future steps include scaling up to pilot and demonstration scales, optimizing for commercial readiness, and conducting a technoeconomic analysis to establish production specifications and cost targets.
zuChem, Inc. is a producer of unique sugars and carbohydrates for human health, nutrition, and pharmaceutical applications. The company utilizes a proprietary carbohydrate biotechnology platform that integrates advanced fermentation, metabolic engineering, and specialized enzyme technologies. By combining these bioprocess methods with traditional chemical techniques, zuChem develops scalable, industrial-quality manufacturing routes for food ingredients, specialty chemicals, and glycochemicals that are otherwise difficult, expensive, or impossible to produce using conventional methods.
These capabilities allow the company to address significant challenges in the food, agricultural, and pharmaceutical industries by providing sustainable and efficient alternatives to energy-intensive chemical production. The company's technology has enabled the commercial production of products such as xylitol from renewable biomass feedstocks. zuChem actively partners with other entities to commercialize its bio-based products and has a history of receiving federal research support, including SBIR awards from the National Institutes of Health, to advance its rare sugar and carbohydrate production technologies.